Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall S Davis

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasinJessica A Campbell, Randall S Davis, Lauren M Lilly, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2003
The inhibitory potential of Fc receptor homolog 4 on memory B cellsGotz R A Ehrhardt, Randall S Davis, Joyce T Hsu, et al.
Gene|November 3, 2005
FcRY, an Fc receptor related gene differentially expressed during B lymphocyte development and activationKeiji Masuda, Randall S Davis, Takako Maruyama, et al.
The Journal of Experimental Medicine|September 15, 2005
Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cellsGötz R A Ehrhardt, Joyce T Hsu, Lanier Gartland, et al.
Immunological Reviews|December 21, 2002
Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene familyRandall S Davis, Glynn Dennis, Mary R Odom, et al.
Protein Engineering, Design & Selection : PEDS|February 17, 2022
Comprehensive mapping of SARS-CoV-2 peptide epitopes for development of a highly sensitive serological test for total and neutralizing antibodiesGarima Kumar, Sarah Sterrett, Lucinda Hall, et al.
Blood Cancer Journal|May 17, 2019
Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation statusLauren K Shea, Kazuhito Honjo, David T Redden, et al.
Nature Immunology|June 15, 2007
IgEb immune complexes activate macrophages through FcgammaRIV bindingMasayuki Hirano, Randall S Davis, W David Fine, et al.
Blood|March 4, 2008
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemiaFu Jun Li, Shouluan Ding, Jicun Pan, et al.
Blood|September 13, 2011
Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemiaFu Jun Li, Yoshiki Kubagawa, Matthew K McCollum, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasinJessica A Campbell, Randall S Davis, Lauren M Lilly, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2003
The inhibitory potential of Fc receptor homolog 4 on memory B cellsGotz R A Ehrhardt, Randall S Davis, Joyce T Hsu, et al.
Gene|November 3, 2005
FcRY, an Fc receptor related gene differentially expressed during B lymphocyte development and activationKeiji Masuda, Randall S Davis, Takako Maruyama, et al.
The Journal of Experimental Medicine|September 15, 2005
Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cellsGötz R A Ehrhardt, Joyce T Hsu, Lanier Gartland, et al.
Immunological Reviews|December 21, 2002
Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene familyRandall S Davis, Glynn Dennis, Mary R Odom, et al.
Protein Engineering, Design & Selection : PEDS|February 17, 2022
Comprehensive mapping of SARS-CoV-2 peptide epitopes for development of a highly sensitive serological test for total and neutralizing antibodiesGarima Kumar, Sarah Sterrett, Lucinda Hall, et al.
Blood Cancer Journal|May 17, 2019
Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation statusLauren K Shea, Kazuhito Honjo, David T Redden, et al.
Nature Immunology|June 15, 2007
IgEb immune complexes activate macrophages through FcgammaRIV bindingMasayuki Hirano, Randall S Davis, W David Fine, et al.
Blood|March 4, 2008
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemiaFu Jun Li, Shouluan Ding, Jicun Pan, et al.
Blood|September 13, 2011
Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemiaFu Jun Li, Yoshiki Kubagawa, Matthew K McCollum, et al.
Pageof 6